Acta Ophthalmologica · 2015 · 95 citations · 18 references
Topical DexNP significantly improve visual acuity and decrease macular thickness in patients with DME. The effect is similar to that from subtenon triamcinolone. A modest increase in IOP was seen with the nanoparticle eye drops, but IOP normalized after the discontinuation of treatment.
18
Michael J. Elman, Neil M. Bressler, Haijing Qin et al. · Ophthalmology · 2011 · 568 citations · Full text
Ranibizumab Plus Prompt, Diabetic Retinopathy, Ocular Disease +7
DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS
David S. Boyer, David Faber, Sunil Gupta et al. · Retina · 2011 · 358 citations